BLUEPRINT GENETICS

A genetics diagnostics company
offering genetics testing to
a global clinical community

 

Blueprint Genetics provides comprehensive genetics testing for all medical specialties. Blueprints innovative technologies in human rare diseases enable improved tests with higher quality, lower cost and faster lead time. We offer full transparency to our technology, quality and performance, and analytic validations of our technologies.

Our expert team of geneticists and clinicians together with our AI powered CLINT technology provide top quality clinical interpretation and reports, changing the standards of molecular diagnostics. We are accredited by ISO 15189 and CAP (#9257331), and certified by CLIA (#99D2092375).

Inventure joined Blueprint Genetics in 2014.

@BpGenetics

We at Blueprint Genetics are recruiting new talentsto work at the forefront of clinical genetic testing! We have several open positions in our Helsinki office:
- Clinical Bioinformaticians
- Software developers
- Geneticists
- ..and more
Check out: https://t.co/Gt4wSB5c5K

Great news! Blueprint Genetics strengthens its pharmaceutical expertise with a new Chairman Hilde Furberg (Recent European Head of Rare Diseases for Sanofi Genzyme) and by appointing Guido Oelkers (CEO of SOB), as a Senior Advisor @BpGenetics https://t.co/e5BV7eBNp8

Great news!! #inventurevc https://t.co/qFyCq9OExj